BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3280194)

  • 1. Oncogene expression in related cancer lines differing in metastatic capacity.
    Pohl J; Radler-Pohl A; Heicappell R; Schirrmacher V
    Clin Exp Metastasis; 1988; 6(3):201-11. PubMed ID: 3280194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.
    Schlatter B; Waghorne CG
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9986-90. PubMed ID: 1438249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c-Ha-ras-1 gene.
    Vousden KH; Eccles SA; Purvies H; Marshall CJ
    Int J Cancer; 1986 Mar; 37(3):425-33. PubMed ID: 3949424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous progression of hyperplastic outgrowths of the D1 lineage to mammary tumors: expression of mouse mammary tumor virus and cellular proto-oncogenes.
    Knepper JE; Kittrell FS; Medina D; Butel JS
    Mol Carcinog; 1989; 1(4):229-38. PubMed ID: 2551332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic ability and expression of c-fos oncogene in cell clones of a spontaneous rat mammary tumor.
    Yuhki N; Hamada J; Kuzumaki N; Takeichi N; Kobayashi H
    Jpn J Cancer Res; 1986 Jan; 77(1):9-12. PubMed ID: 3082820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage.
    Larizza L; Schirrmacher V; Graf L; Pflüger E; Peres-Martinez M; Stöhr M
    Int J Cancer; 1984 Nov; 34(5):699-707. PubMed ID: 6500746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal heterogeneity, experimental metastatic ability, and p21 expression in H-ras-transformed NIH 3T3 cells.
    Hill SA; Wilson S; Chambers AF
    J Natl Cancer Inst; 1988 Jun; 80(7):484-90. PubMed ID: 3285012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of hst gene expression with metastatic phenotype in mouse mammary tumors.
    Murakami A; Tanaka H; Matsuzawa A
    Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
    McKenzie KE; Armstrong BA; Chen Y; Nagarajan M; Aldaz CM; Sukumar S
    Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells.
    Ichikawa T; Ichikawa Y; Isaacs JT
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1607-10. PubMed ID: 1542651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumorigenicity in human cell hybrids derived from cell lines expressing different activated ras oncogenes.
    Geiser AG; Anderson MJ; Stanbridge EJ
    Cancer Res; 1989 Mar; 49(6):1572-7. PubMed ID: 2647289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
    Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
    Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harvey-ras mediated neoplastic development in the mouse mammary gland.
    Strange R; Aguilar-Cordova E; Young LJ; Billy HT; Dandekar S; Cardiff RD
    Oncogene; 1989 Mar; 4(3):309-15. PubMed ID: 2784851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection for spontaneous metastasis after calcium phosphate-mediated transfer of DNA.
    Muschel RJ
    Cancer Res; 1990 Sep; 50(17):5581-6. PubMed ID: 2201438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between Ha-ras gene amplification and spontaneous metastasis in NIH 3T3 cells transfected with genomic DNA from human skin cancers.
    Ananthaswamy HN; Price JE; Tainsky MA; Goldberg LH; Bales ES
    Clin Exp Metastasis; 1989; 7(3):301-13. PubMed ID: 2647332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
    Waghorne C; Kerbel RS; Breitman ML
    Oncogene; 1987 May; 1(2):149-55. PubMed ID: 3325879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoconjugates of murine tumor lines with different metastatic capacities. I. Differences in fucose utilization and in glycoprotein patterns.
    Schwartz R; Schirrmacher V; Mühlradt PF
    Int J Cancer; 1984 Apr; 33(4):503-9. PubMed ID: 6706434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.